NCT00927719View on ClinicalTrials.gov

Safety Surveillance Study of ACAM2000® Vaccinia Vaccine

CompletedOBSERVATIONAL
Enrollment

897,227

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Smallpox
Interventions
BIOLOGICAL

ACAM2000® smallpox vaccine

Previous vaccination, no vaccine is administered in this study.

Trial Locations (4)

42223

Fort Campbell North

76544

Fort Hood

79906

Fort Bliss

92278

Twentynine Palms

Sponsors
All Listed Sponsors
lead

Emergent BioSolutions

INDUSTRY